NCMI

National CineMedia, Inc. NASDAQ Listed Feb 8, 2007

Communication Services ·Advertising Agencies ·US · ncm.com

$3.58

After hrs $3.56 -0.56%

Mkt Cap $333.9M

52w Low $2.92 25.0% of range 52w High $5.56

50d MA $3.38 200d MA $3.99

P/E (TTM) -31.0x

EV/EBITDA 13.1x

P/B 0.8x

Debt/Equity 0.1x

ROE -2.8%

P/FCF 130.8x

RSI (14) —

ATR (14) —

Beta 1.42

50d MA $3.38

200d MA $3.99

Avg Volume 489.0K

About

National CineMedia, Inc., through its subsidiary, National CineMedia, LLC, operates cinema advertising network in North America. It engages in the sale of advertising to national, regional, and local businesses in Noovie, a cinema advertising and entertainment pre-show seen on movie screens; and sells advertising on its Lobby Entertainment Network, a series of strategically-placed screens located …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	0.25	0.28	+12.0%	3.51	+3.1%	+1.4%	+2.8%	+0.9%	+1.4%	-0.3%	—
Oct 30, 2025	AMC	-0.03	0.02	+156.7%	4.04	+4.7%	+9.4%	+10.1%	+6.4%	+7.2%	+2.5%	—
Aug 5, 2025	AMC	-0.11	-0.11	+0.0%	4.54	+7.7%	+3.3%	-0.7%	-2.6%	+0.2%	+2.4%	—
May 6, 2025	AMC	-0.20	-0.24	-20.0%	5.80	-29.0%	-11.6%	-14.7%	-12.6%	-12.1%	-8.8%	—
Mar 6, 2025	AMC	0.20	0.26	+30.0%	6.35	-10.2%	-17.8%	-15.1%	-15.7%	-12.9%	-10.1%	—
Nov 5, 2024	AMC	-0.03	-0.04	-48.1%	7.30	+0.7%	-10.5%	-9.5%	-13.7%	-10.7%	-7.4%	—
Aug 5, 2024	AMC	-0.08	-0.09	-12.5%	5.28	+8.1%	+19.1%	+13.4%	+14.8%	+15.2%	+12.1%	—
May 6, 2024	AMC	-0.08	-0.19	-137.5%	4.83	-12.0%	-4.6%	-2.9%	-5.4%	-6.8%	-6.2%	—
Mar 18, 2024	AMC	0.09	0.24	+166.7%	4.22	+22.7%	+19.9%	+23.5%	+25.8%	+33.4%	+26.8%	—
Nov 7, 2023	AMC	-0.14	0.33	+335.7%	3.89	+5.4%	+11.8%	+10.5%	+8.2%	+6.4%	+12.6%	—
Aug 1, 2023	AMC	-9.50	-0.70	+92.6%	3.70	+0.0%	-7.3%	-7.3%	-14.1%	-20.5%	-12.2%	—
May 9, 2023	AMC	-1.30	-3.10	-138.5%	3.15	+1.6%	+0.6%	+1.6%	-2.2%	-11.4%	-14.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 26	Barrington Research	Maintains	Outperform → Outperform	—	$3.75	$3.73	-0.5%	-1.1%	-0.5%	-3.7%	-3.7%	-3.7%
Jan 22	B. Riley Securities	Maintains	Neutral → Neutral	—	$3.81	$3.76	-1.3%	+0.3%	-1.6%	-2.6%	-2.1%	-5.2%
Jan 7	Benchmark	Maintains	Buy → Buy	—	$4.02	$4.02	+0.0%	-6.2%	-5.2%	-5.2%	-5.2%	-5.2%
Oct 31	Barrington Research	Maintains	Outperform → Outperform	—	$4.04	$4.23	+4.7%	+9.4%	+10.1%	+6.4%	+7.2%	+2.5%
Aug 4	Wedbush	Maintains	Outperform → Outperform	—	$4.67	$4.70	+0.6%	+1.7%	-2.8%	+0.4%	-3.4%	-5.4%
Jun 25	Benchmark	Maintains	Buy → Buy	—	$5.23	$5.14	-1.7%	-5.9%	-6.5%	-6.5%	-7.3%	-7.8%
Mar 14	Wedbush	Upgrade	Neutral → Outperform	—	$5.71	$6.05	+6.0%	+4.2%	+2.1%	+0.7%	+6.5%	+1.9%
Mar 14	Barrington Research	Maintains	Outperform → Outperform	—	$5.71	$6.05	+6.0%	+4.2%	+2.1%	+0.7%	+6.5%	+1.9%
Mar 7	Benchmark	Maintains	Buy → Buy	—	$6.35	$5.70	-10.2%	-17.8%	-15.1%	-15.7%	-12.9%	-10.1%
Mar 7	Barrington Research	Maintains	Outperform → Outperform	—	$6.35	$5.70	-10.2%	-17.8%	-15.1%	-15.7%	-12.9%	-10.1%
Nov 6	Barrington Research	Maintains	Outperform → Outperform	—	$7.30	$7.35	+0.7%	-10.5%	-9.5%	-13.7%	-10.7%	-7.4%
Aug 16	B. Riley Securities	Maintains	Buy → Buy	—	$6.40	$6.44	+0.6%	+2.5%	+5.5%	+6.7%	+8.4%	+7.2%
Aug 15	Benchmark	Maintains	Speculative Buy → Buy	—	$6.12	$6.69	+9.3%	+4.6%	+7.2%	+10.3%	+11.6%	+13.4%
Aug 6	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$5.28	$5.71	+8.1%	+19.1%	+13.4%	+14.8%	+15.2%	+12.1%
Aug 6	Barrington Research	Upgrade	Market Perform → Outperform	—	$5.28	$5.71	+8.1%	+19.1%	+13.4%	+14.8%	+15.2%	+12.1%
Jun 17	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$4.61	$4.65	+0.9%	+0.4%	-2.0%	-5.6%	-4.8%	-7.8%
May 7	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$4.83	$4.25	-12.0%	-4.6%	-2.9%	-5.4%	-6.8%	-6.2%
Mar 20	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$5.06	$5.19	+2.6%	+3.0%	+4.9%	+11.3%	+5.7%	+4.3%
Mar 19	Wedbush	Maintains	Neutral → Neutral	—	$4.22	$5.18	+22.7%	+19.9%	+23.5%	+25.8%	+33.4%	+26.8%
Mar 19	B. Riley Securities	Upgrade	Neutral → Buy	—	$4.22	$5.18	+22.7%	+19.9%	+23.5%	+25.8%	+33.4%	+26.8%
Mar 12	Wedbush	Maintains	Neutral → Neutral	—	$3.85	$3.86	+0.3%	+0.5%	+6.0%	+6.0%	+10.1%	+9.6%
Nov 8	Wedbush	Maintains	Neutral → Neutral	—	$3.89	$4.10	+5.4%	+11.8%	+10.5%	+8.2%	+6.4%	+12.6%
Sep 22	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$4.56	$4.76	+4.4%	+4.2%	+2.9%	-1.3%	-2.4%	-2.4%
Aug 25	Benchmark	Maintains	Speculative Buy → Speculative Buy	—	$4.32	$4.40	+1.9%	-0.9%	-1.6%	-1.6%	+6.5%	+4.9%
Aug 16	Benchmark	Upgrade	Hold → Speculative Buy	—	$3.55	$3.76	+5.9%	+4.5%	-1.4%	+8.7%	+18.6%	+18.3%
Aug 3	Wedbush	Downgrade	Outperform → Neutral	—	$3.43	$3.34	-2.6%	+0.0%	-7.3%	-14.3%	-5.2%	+7.9%
Apr 19	Wedbush	Maintains	Outperform → Outperform	—	$3.50	$3.35	-4.3%	+8.3%	+0.3%	+1.1%	-16.3%	-27.7%
Apr 12	Wedbush	Maintains	Outperform → Outperform	—	$2.06	$3.02	+46.6%	+114.6%	+107.8%	+68.9%	+82.0%	+69.9%
Oct 3	Benchmark	Downgrade	Buy → Hold	—	$6.52	$6.50	-0.3%	-13.7%	-10.7%	-12.9%	-18.9%	-21.8%
Sep 26	B. Riley Securities	Maintains	Neutral → Neutral	—	$8.95	$8.80	-1.7%	-4.9%	-16.0%	-13.7%	-22.3%	-27.2%
Jun 21	B. Riley Securities	Maintains	Neutral → Neutral	—	$12.10	$12.00	-0.8%	-9.9%	-14.0%	-11.6%	-8.3%	-15.7%
Apr 13	B. Riley Securities	Maintains	Buy → Buy	—	$23.40	$23.20	-0.9%	+4.3%	+4.7%	+6.4%	+9.0%	+5.1%
Nov 4	Wedbush	Upgrade	Neutral → Outperform	—	$35.30	$36.40	+3.1%	+0.6%	+6.5%	+10.2%	+5.1%	+3.7%
Apr 7	Benchmark	Upgrade	Hold → Buy	—	$46.60	$49.80	+6.9%	-3.0%	-0.9%	-3.6%	-3.6%	-10.3%
Oct 9	MKM Partners	Maintains	Neutral → Neutral	—	$26.80	$26.40	-1.5%	-4.9%	-7.1%	-15.3%	-16.0%	-16.8%
Sep 4	Barrington Research	Upgrade	Market Perform → Outperform	—	$35.90	$37.80	+5.3%	+28.1%	+13.1%	+14.8%	+3.9%	-4.7%
Jul 29	Wedbush	Downgrade	Outperform → Neutral	—	$29.40	$29.30	-0.3%	-7.8%	-11.9%	-16.0%	-9.9%	-2.7%
May 6	B. Riley FBR	Maintains	Buy → Buy	—	$30.30	$30.00	-1.0%	-4.0%	-2.6%	+5.3%	+4.3%	+0.3%
May 5	B. Riley Securities	Maintains	Buy → Buy	—	$30.80	$31.00	+0.6%	-1.6%	-5.5%	-4.2%	+3.6%	+2.6%
May 4	Wedbush	Maintains	Outperform → Outperform	—	$31.40	$30.30	-3.5%	-1.9%	-3.5%	-7.3%	-6.1%	+1.6%
Apr 9	MKM Partners	Maintains	Neutral → Neutral	—	$29.70	$30.00	+1.0%	-2.0%	-7.4%	-10.1%	-14.5%	-9.8%
Mar 18	B. Riley FBR	Maintains	Buy → Buy	—	$27.10	$26.10	-3.7%	-31.4%	+11.4%	-0.4%	+5.2%	+17.0%
Mar 18	Benchmark	Downgrade	Buy → Hold	—	$27.10	$26.10	-3.7%	-31.4%	+11.4%	-0.4%	+5.2%	+17.0%
Mar 17	B. Riley Securities	Maintains	Buy → Buy	—	$31.10	$31.20	+0.3%	-12.9%	-40.2%	-2.9%	-13.2%	-8.4%
Mar 2	B. Riley	Upgrade	Neutral → Buy	—	$76.90	$76.20	-0.9%	-2.7%	-6.6%	-8.1%	-15.1%	-17.6%
Mar 1	B. Riley Securities	Upgrade	Neutral → Buy	—	—	—	—	—	—	—	—	—
Feb 21	Wedbush	Maintains	Outperform → Outperform	—	$80.00	$92.10	+15.1%	+17.1%	+9.1%	+4.9%	+3.6%	+0.8%
Feb 21	B. Riley FBR	Maintains	Neutral → Neutral	—	$80.00	$92.10	+15.1%	+17.1%	+9.1%	+4.9%	+3.6%	+0.8%
Feb 20	B. Riley Securities	Maintains	Neutral → Neutral	—	$79.30	$79.40	+0.1%	+0.9%	+18.2%	+10.1%	+5.9%	+4.5%
Nov 7	Barrington Research	Upgrade	Market Perform → Outperform	—	$71.30	$74.80	+4.9%	+6.3%	+6.6%	+6.0%	+6.7%	+1.5%

Insider Trades

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
May 4, 2026	Woods Maria VG	Chief Legal Officer	Sell	5,509	$3.45	$19K	149,387	+3.47%	—
May 4, 2026	Ng Ronnie Y.	Chief Financial Officer	Sell	12,925	$3.45	$45K	204,757	+3.47%	—
May 4, 2026	Lesinski Thomas F.	Chief Executive Officer	Sell	20,181	$3.45	$70K	568,559	+3.47%	—

Recent Filings

8-K

Unknown — 8-K Filing

Creative Realities (CREX) completed CDM integration and projects strong 2025 results, suggesting operational momentum that could drive growth and justify investor confidence in management's execution capability.

Apr 14

8-K · 5.03 ! Medium

Unknown — 8-K 5.03: Amendment to Articles / Bylaws

NCMI reduced its board from an unspecified number to seven directors, likely streamlining governance and reducing overhead costs while maintaining operational control.

Mar 27

8-K

National CineMedia, Inc. -- 8-K Filing

National CineMedia released a press statement via 8-K filing, likely containing material company updates, though specific business developments require reviewing the attached press release exhibit.

Feb 27

8-K

National CineMedia, Inc. -- 8-K Filing

National CineMedia exceeded fourth-quarter adjusted OIBDA guidance with 8% revenue growth driven by stronger advertising demand, outpacing theater attendance gains.

Feb 26

Data updated apr 26, 2026 2:28pm · Source: massive.com